3Lombardo J, Burkom H, Elbert E. A systems overview of the electronic surveillance system for the early notification of community-based epidemics (ESSENCE Ⅱ ) [J]. J Urban Health, 2003,80 (2, Suppl 1 ) : i32-42.
4Tsui FC, Espino JU, Dato VM, et al. Technical description of RODS: a real-time public health surveillance system [J]. J Am Med Inform Assoc, 2003,10(5):399-408.
5Henning KJ. What is syndromic surveillance [J]. MMWR Morb Mortal Wkly Rep, 2004,53 (Suppl) : 5-11.
6Allard R. Use of time-series analysis in infectious disease surveillance [J]. Bull World Health Organ, 1998,76 (4) : 327-333.
7Reis BY, Mandl KD. Time series modeling for syndromic surveillance [J]. BMC Med Inform Decis Mak, 2003(3):2.
8Buckeridge DL, Switzer P, Owens D, et al. An evaluation model for syndromic surveillance: assessing the performance of a temporal algorithm [J]. MMWR Morb Mortal Wkly Rep, 2005,54 (Suppl) : 109-115.
9Lewis MD, Pavlin JA, Mansfield JL, et al. Disease outbreak detection system using syndromic data in the greater Washington DE area [J]. Am J Prev Med, 2002,23(3): 180-186.
10Kleinman K, Lazarus R, Platt R. A generalized linear mixed models approach for detecting incident clusters of disease in small areas, with an application to biological terrorism [J]. Am J Epidemiol, 2004,159(3) :217-224.
二级参考文献34
1Bartlett JG,Breiman RF,Mandell LA,et al. Community-acquired pneumonia in adults:guidelines for management.The Infectious Diseases Society of America. Clin Infect Dis,1998 ,26:811-838.
2Lim WS,Macfarlane JT,Boswell TC,et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax,2001,56:296-301.
3Gomez J,Banos V,Ruiz Gomez J,et al. Prospective study of epidemiology and prognostic factors in community-acquired pneumonia. Eur J Clin Microbiol Infec Dis,1996,15:556-560.
4Torres A,El Ebiary M,Riquelme R,et al. Community-acquired pneumonia in the elderly. Semin Respir Infect,1999,14:173-183.
5Higuera F,Hidalgo H,Feris J,et al. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia. J Antimicrob Chemother,1996 ,37:555-564.
6Bollowa JGM. The reliability of sputum typing and its relation to serum therapy. JAMA,1935,105:1512-1518.
8Lieberman D,Schlaeffer F,Boldur I,et al. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorox,1996 ,51:179-184.
9Ruiz-Gonzalez A,Falguera M,Nogues A,et al. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology?A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am J Med,1999,106:385-390.
10Kauppinen MT,Herva E,Kujala P,et al.The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis,1995 ,172:1330-1335.
5Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children [ J ]. New England Journal of Medicine, 2009, 360 (6) : 588 -598.
6Shindo N. Making progress on the WHO Public Health Research Agenda for Influenza [ J ]. Influenza and Other Respiratory Viruses, 2013 (7): 1-3.
